Patrick Machado - 10 Jun 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Director
Signature
Patrick Machado, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4
Filing time
14 Jun 2022, 16:19:31 UTC
Previous filing
01 Oct 2021
Next filing
16 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADVM Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 10 Jun 2022 Common Stock 40,000 $0.9903 Direct F1
transaction ADVM Stock Option (Right to Buy) Award $0 +12,500 $0.000000 12,500 10 Jun 2022 Common Stock 12,500 $0.9903 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 10, 2023 or the 2023 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.